PAG
MRNA icon

Private Advisor Group’s Moderna MRNA Stock Holding History

Private Advisor Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$448K Sell
6,392
-420
-6% -$21.7K ﹤0.01% 1870
2026
Q1 		$346K Sell
6,812
-3,130
-31% -$146K ﹤0.01% 2096
2025
Q4 		$293K Sell
9,942
-3,527
-26% -$95.8K ﹤0.01% 2173
2025
Q3 		$348K Buy
13,469
+134
+1% +$3.74K ﹤0.01% 1987
2025
Q2 		$368K Buy
13,335
+2,529
+23% +$66.6K ﹤0.01% 1853
2025
Q1 		$306K Sell
10,806
-13,174
-55% -$467K ﹤0.01% 1862
2024
Q4 		$997K Sell
23,980
-474
-2% -$22.7K 0.01% 1220
2024
Q3 		$1.63M Sell
24,454
-6,279
-20% -$576K 0.01% 987
2024
Q2 		$3.65M Buy
30,733
+16,243
+112% +$2.06M 0.02% 603
2024
Q1 		$1.54M Sell
14,490
-104
-0.7% -$10.5K 0.01% 940
2023
Q4 		$1.45M Buy
14,594
+1,261
+9% +$106K 0.01% 918
2023
Q3 		$1.38M Buy
13,333
+991
+8% +$111K 0.01% 878
2023
Q2 		$1.5M Sell
12,342
-1,258
-9% -$168K 0.01% 851
2023
Q1 		$2.09M Sell
13,600
-901
-6% -$149K 0.02% 661
2022
Q4 		$255K Buy
14,501
+1,327
+10% +$217K 0.01% 812
2022
Q3 		$1.56M Sell
13,174
-9,498
-42% -$1.44M 0.02% 726
2022
Q2 		$3.24M Buy
22,672
+1,940
+9% +$277K 0.03% 559
2022
Q1 		$3.57M Buy
20,732
+60
+0.3% +$10.1K 0.03% 569
2021
Q4 		$5.25M Sell
20,672
-16,283
-44% -$4.76M 0.04% 437
2021
Q3 		$14.2M Buy
36,955
+16,417
+80% +$6.05M 0.09% 225
2021
Q2 		$4.83M Buy
20,538
+2,364
+13% +$422K 0.04% 415
2021
Q1 		$2.38M Buy
18,174
+2,034
+13% +$295K 0.02% 639
2020
Q4 		$1.69M Sell
16,140
-2,197
-12% -$222K 0.02% 719
2020
Q3 		$1.28M Sell
18,337
-1,698
-8% -$118K 0.02% 695
2020
Q2 		$1.29M Buy
20,035
+10,631
+113% +$582K 0.02% 663
2020
Q1 		$282K Buy
+9,404
New +$216K 0.01% 1097

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Private Advisor Group's MRNA Position: Q2 2026 in Review

Private Advisor Group reduced its Moderna (MRNA) stake by 6.2% in Q2 2026, selling an estimated $21.7K and leaving 6,392 shares worth $448K. The position accounts for ﹤0.01% of the portfolio, ranked #1870.

Private Advisor Group first reported a position in MRNA in Q1 2020 and has held it in 26 quarters since. The position peaked at $14.2M in Q3 2021. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Private Advisor Group held 6,392 shares of Moderna worth $448K as of Q2 2026.
  • Private Advisor Group sold 420 Moderna shares in Q2 2026, an estimated $21.7K.
  • Moderna made up ﹤0.01% of Private Advisor Group's portfolio in Q2 2026, its #1870 holding.
  • Private Advisor Group first reported a position in Moderna in Q1 2020 and has held it in 26 quarters since.
  • Private Advisor Group's Moderna position peaked at $14.2M in Q3 2021.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.